Quest Diagnostics' stock price surged 5.32% in pre-market trading on Thursday, indicating strong investor interest ahead of the regular session.
The significant price movement appears to be driven by the company's latest quarterly results, which showed Q2 revenue of $3,043 million, surpassing analyst estimates of $2,967 million. This positive earnings surprise has likely boosted investor confidence in the company's financial performance.